Product
68Ga-FAP-2286
2 clinical trials
4 indications
Indication
Solid TumorIndication
Fibrosis of the LiverIndication
Pulmonary FibrosisIndication
Cardiac FibrosisClinical trial
LuMIERE: A Phase 1/2, Multicenter, Open-label, Non-randomized Study to Investigate Safety and Tolerability, Pharmacokinetics, Dosimetry, and Preliminary Activity of 177Lu-FAP-2286 in Patients With an Advanced Solid TumorStatus: Active (not recruiting), Estimated PCD: 2026-06-30
Clinical trial
Imaging of Pathologic Fibrosis Using 68Ga-FAP-2286Status: Recruiting, Estimated PCD: 2024-12-31